We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Federal Court Invalidates Claims on Schering’s Zetia Patent
Federal Court Invalidates Claims on Schering’s Zetia Patent
April 27, 2010
A federal court has ruled certain claims on a patent for Schering-Plough’s cholesterol treatment Zetia are invalid, a move that may help Glenmark Pharmaceuticals win approval for a generic version of the drug.